S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

SONN Sonnet BioTherapeutics Holdings Inc

1.42

-0.02 (-1.39%)

Dec 24 2024 - Closed

Delayed by 15 minutes

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Article too big to display. Click here to view on the SEC website

Sonnet BioTherapeutics (NASDAQ:SONN)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Sonnet BioTherapeutics Charts.

Sonnet BioTherapeutics (NASDAQ:SONN)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Sonnet BioTherapeutics Charts.

Sonnet BioTherapeutics Holdings Inc News

Form D - Notice of Exempt Offering of Securities
Monday 23 December 2024 (2 days ago) • Edgar (US Regulatory)

Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment
Monday 23 December 2024 (2 days ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 17 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 17 December 2024 (1 week ago) • Edgar (US Regulatory)

Sonnet BioTherapeutics Reports Fiscal Year 2024 Financial Results and Provides Corporate Update
Tuesday 17 December 2024 (1 week ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 10 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Tuesday 10 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Sonnet BioTherapeutics Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Monday 9 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 9 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Sonnet BioTherapeutics Announces Topline Safety Data Following Successful Completion of SON-1010 Monotherapy Dose Escalation in Phase 1 SB101 Trial
Monday 9 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 December 2024 (3 weeks ago) • Edgar (US Regulatory)

More Sonnet BioTherapeutics Holdings Inc News Articles

North Bay Resources (PK)

Anavex Life Sciences

Intergrated Cannabis Sol... (PK)

Digital Brand Media and ... (PK)

Fannie Mae (QB)

Northwest Biotherapeutics (QB)

Code Green Apparel (PK)

Lightwave Logic

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions